Jayson Rieger
-
West Chester’s Verrica Pharmaceuticals Doubles Ycanth Revenue After Sales Strategy Shift
After overhauling its sales strategy, West Chester-based Verrica Pharmaceuticals more than doubled revenues from Ycanth, its flagship treatment for skin diseases, compared with last year, writes John George for…
-
With New $50 Million Infusion, West Chester’s Verrica Pharmaceuticals to Retire Debt
West Chester-based Verrica Pharmaceuticals has secured $50 million from a private stock sale, which will allow the company to retire its $35 million OrbiMed debt and finance future business activities,…
Pioneer Partner
Founding Partners
Advertisement
Affiliate Partners
Community Partners
